BioSpace News Archive

Business

LuxCath Appoints Terry Ransbury as Chief Technology Officer

Company Also Announces Two Medtech Veteran Additions Rick Randall and John Fletcher to its Board of Directors

October 4, 2018
·
6 min read
Genetown

Deloitte/MIT Study Finds Biopharma Companies Seek Digital Transformation, But Most Are Lagging

Fourth Annual Digital Business Global Executive Survey Reveals Cultural, Leadership and Funding Challenges That Must Be Addressed

October 4, 2018
·
5 min read
BioMidwest

Walgreens and Birchbox to Offer Customers Innovative Beauty Experience In-Store and Online

Strategic collaboration will combine Walgreens convenient store footprint and beauty experience with Birchbox’s prestige brands and unique merchandising perspective

October 4, 2018
·
4 min read
Drug Development

KaNDy Therapeutics presents new compelling data with lead candidate NT-814 at The North American Menopause Society 2018 Annual Meeting

Treatment with NT-814 resulted in immediate improvements in bothersome post-menopausal symptoms

October 4, 2018
·
5 min read
Drug Development

Study Opens of BeyondSpring’s Lead Asset, Plinabulin, and Nivolumab + Ipilimumab in Small-Cell Lung Cancer

Rutgers Trial Aims to Demonstrate Reduction in Immune-Related Adverse Events, While Adding to Anti-Cancer Immune Effects for Patients

October 4, 2018
·
4 min read
Business

SIGA Enters into Cooperative Research and Development Agreement with U.S. Army Medical Research Institute of Infectious Disease to Evaluate the Efficacy of TPOXX® as a Post-Exposure Prophylactic for Smallpox

SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

October 4, 2018
·
5 min read
Lone Star Bio

Pain Therapeutics Announces $3.5 Million NIH Grant Award to Study Alzheimer’s Disease

NIH Grant Will Enable Clinical Tests of PTI-125 in Patients with Alzheimer’s Disease

October 4, 2018
·
3 min read
Pharm Country

Eisai Announces New Data on the Effect of Anti-Obesity Agent BELVIQ® (lorcaserin HCl) on Prevention and Remission of Type 2 Diabetes Presented at the European Association for the Study of Diabetes (EASD) and Published in The Lancet

In secondary metabolic analyses of CAMELLIA-TIMI 61, patients with pre-diabetes who were treated with BELVIQ were less likely to develop diabetes and had a greater tendency to achieve normal blood glucose levels compared to patients treated with placebo

October 4, 2018
·
11 min read
Drug Development

Ophthotech Completes Patient Recruitment As Planned for its Phase 2b Clinical Trial of Zimura® Monotherapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Initial Top-line Zimura Geographic Atrophy Data Expected in the Fourth Quarter of 2019

October 4, 2018
·
5 min read
Business

Arrowhead Enters $3.7 Billion License and Collaboration Agreements with Janssen

Upon closing, Arrowhead to receive $250 million, consisting of $175 million upfront payment from Janssen and $75 million equity investment from Johnson & Johnson Innovation – JJDC, Inc.

October 4, 2018
·
6 min read